Target intelligence / Profile preview

PYM homolog 1, exon junction complex associated factor (PYM1)

Target
PYM1
Molecular classification
Other, RNA-binding protein, Exon junction complex-associated factor
01

Overview

PYM homolog 1, exon junction complex associated factor (PYM1) is a protein-coding gene that encodes a key regulator of the exon junction complex (EJC), a multiprotein assembly deposited upstream of exon-exon junctions of mRNA during splicing[1][2][5]. PYM1 acts in EJC disassembly, particularly through a translation-independent mechanism, helping to ensure the proper removal and recycling of EJCs after mRNA processing and during translation[2][3]. The protein interacts directly with both the MAGOH/RBM8A heterodimer of the EJC and small ribosomal subunit, and has been shown to modulate mRNA fate, influencing processes such as nonsense-mediated decay (NMD) and translation efficiency[2][4][5]. PYM1 is sometimes hijacked by certain viruses (e.g., flaviviruses) to alter host mRNA regulation[2]. The gene is primarily classified in the exon junction complex associated factor family and does not act as a classical receptor, enzyme, transporter, or primary therapeutic target. There are no established drugs targeting PYM1, and its alterations are not currently used as clinical biomarkers or linked to prominent safety concerns[1][2][5].

Other names
WIBGPartner of Y14 and MagoPYMPYM homolog 1protein wibg homologwithin bgcn homologPYM1
02

Biological functions

Exon-exon junction complex disassemblymRNA catabolic process (especially nonsense-mediated decay)Positive regulation of translationRegulation of mRNA exportControl of post-transcriptional gene expression
03

Disease associations

Other (no direct, established role in cancer, inflammation, infection, cardiovascular, or neurodegenerative disease; limited association with Palmoplantar Keratoderma, Punctate Type Ia)

Beyond the preview

Go deeper on PYM homolog 1, exon junction complex associated factor (PYM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PYM homolog 1, exon junction complex associated factor (PYM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call